Classes
- Complex approach to urological tumorsD01000109 | Second Faculty of Medicine
- OS - Complex approach to urological tumors +1DVA1029 | Second Faculty of Medicine
- OS - Miniinvasive surgery in urology +1DVA1030 | Second Faculty of Medicine
- Practical UrologyD0100064 | Second Faculty of Medicine
- Basic principles of clinical researchD01000124 | Second Faculty of Medicine
- Clinical 10 days - Department of Urology +1DA0110URO | Second Faculty of Medicine
Publications
- Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels2025 | First Faculty of Medicine, Second Faculty of Medicine
- European Urology Oncology Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer2025 | First Faculty of Medicine, Second Faculty of Medicine
- An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial2025 | Second Faculty of Medicine
- European Urology Focus Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis2025 | Second Faculty of Medicine
- Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma2024 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?2024 | First Faculty of Medicine, Second Faculty of Medicine
- Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study2024 | Second Faculty of Medicine
- Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study2024 | Second Faculty of Medicine
- Similar immune responses to alpha1-oleate and Bacillus Calmette-Guérin treatment in patients with bladder cancer2024 | Second Faculty of Medicine
- Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer2024 | Second Faculty of Medicine
Loading network view...
